Significance of busulfan administration route including therapeutic drug monitoring in the conditioning regimen of pediatric patients prior to hematopoietic stem cell transplantation
Stephanie Hämmerle(Jena University Hospital), Bernd Gruhn(Jena University Hospital), Till Milde, R. Steiner(University Hospital Zurich), Tayfun Güngör, Jana Ernst(Comprehensive Cancer Center Mainfranken)
Cited by 2
Related Papers
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
|Blood|2020|166
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency
|Journal of Allergy and Clinical Immunology|2015|141
DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans
|Journal of Clinical Investigation|2019|131